2018 Pilot Grant Program in Addiction Science

March 1, 2018

   

Program Description

The objective of the pilot grant program is to support transformative ideas in addiction science that engage new teams in multiple disciplines and to generate preliminary data for external funding submissions. The maximum award will be $75,000 for the total duration of the project. Recipients will have up to two years to complete projects. We expect to support 4-5 proposals. This grant is not intended to sustain existing work and must be applied to new unfunded projects.

Application Instructions

Applications will be accepted through April 30, 2018. Recipients will be notified of awards by early Summer 2018. Applications should be submitted electronically by completing the online application survey, which will include uploading required materials. 

More information on the application and its requirements.

About the Medical Discovery Team on Addiction

The University of Minnesota's Medical Discovery Team on Addiction is a multi-departmental endeavor across the University of Minnesota Medical School to advance research and treatment in the field of drug addiction. The overarching vision of the Medical Discovery Team on Addiction is to link basic research to new therapeutic approaches to treating substance abuse. The State of Minnesota has appropriated significant funds over the next ten years for the Medical School to create a world-class, neuroscience-based program for the study and treatment of addiction.

Share this post

You may also like:

Paula M. Termuhlen, MD, is among a group of 91 esteemed surgeons from seven countries selected into membership in the new American College of Surgeons (ACS) Academy of Master Surgeon Educators. 

The University of Minnesota Medical School is proud to announce Macaran “Mac” Baird, MD, MS, professor emeritus and retired Head of the Department of Family Medicine and Community Health has been named the 2018 Shotwell Award recipient by Twin Cities Medical Society.

After years of clinical testing, Oculogica has launched their newest medical device created by the Department of Neurosurgery’s Uzma Samadani, MD, PhD.